Filters

Mouse Anti-Polyomavirus (KV, Pneumotropic virus) Capsid Protein 1 (VP1) antibody negative control serum

Mouse Anti-Polyomavirus (KV, Pneumotropic virus) Capsid Protein 1 (VP1) antibody negative control serum size: 1 mL 188

Supplier ADI
Price 188
Size 1 mL
ELISA kit stock availabilityAvailable In Stock
ELISA's description Pneumotropic virus) Capsid Protein 1 (VP1) antibody negative control serum, Mouse Anti-Polyomavirus (KV
CategoryControl Serum
S typen/a
Antibody's host issee techfile
PurificationAffinity purified
Description Azide Free Serum for cell culture FBS fetal bovine serum, Filtered serum for sterility, Plasmas on request, Serum includes all , The polyclonal serum contains no red or white blood cells or , and any , antibodies and deactivated samples, it is the blood plasma ,  ,  ,  , (coagulation) and all the , Isotype or positive controls by peptides, and antibodies not used in , and , antibodies, antigens, blood clotting , clotting factors, electrolytes, exogenous , fibrinogens, hormones, microorganisms, not including the , proteins , substances like drugs 
Test A/J, BALB/c, Mouse are mature after 40 days for females and 55 days for males, SCID while the CD-1 is outbred as strain, The female mice are pregnant only 20 days and can give birth to 10 litters of 6-8 mice a year, Transgenic, congenic and inbread strains are known for C57BL/6, knock-out, Mouse , mice from the Mus musculus species are used for production of mouse monoclonal antibodies or mabs and as research model for humans in your lab, or 
Latin nameMus musculus
AboutC, Serum should be stored at +5°
French translationanticorps
Gene target Pneumotropic virus) Capsid Protein 1 (VP1), Polyomavirus (KV
Short name Pneumotropic virus) Capsid Protein 1 (VP1) antibody negative control serum, Mouse Anti-Polyomavirus (KV
Technique mouses, Mouse
Species Mouses, Mouse
Alternative name Pneumotropic virus) Capsid Protein 1 (VP1) (Antibody to) negative reference blood serum, Mouse antibody to-Polyomavirus (KV
Alternative techniquemurine

Subscribe to our Newsletter